Xpogen Licenses PathlinX Software to Johns Hopkins

May 08, 2003

NEW YORK, May 8 - Bioinformatics company Xpogen today said it has licensed its PathlinX 3.0 gene expression-analysis software to Johns Hopkins Medical Center.

According to Cambridge, Mass.-based Xpogen, the PathlinX software was designed to identify differentially co-expressed genes in two-state method-of-action experiments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Last of the Northern White Rhinoceroses, Sequenced

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

DNA Phenotyping Allowed in Bavaria

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Thanks for the Stress, Dad

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

This Week in Science

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Main menu